Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021
- SKU ID : TNV-IRTNTR15555 11234166
- |
- Publishing Date: 15-Nov-2017
- |
- Region: Global
- |
- No. of pages: 93
About Coronary Artery Bypass Grafts (CABG)
CABG is a surgical procedure performed to improve blood flow to the heart. It is used for patients suffering with a severe coronary heart disease (CHD). CHD is a disease that leads to deposition of plaque inside arteries and disrupts the flow of oxygen to the heart. During the CABG procedure, a healthy artery or vein from the body is connected or grafted to the blocked coronary artery to create a new path for oxygen-rich blood to flow to the heart muscle.
Technavio’s analysts forecast the global coronary artery bypass grafts (CABG) market to grow at a CAGR of 5.83% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global coronary artery bypass grafts (CABG) market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott
• MAQUET
• Medtronic
• Terumo Medical
Other prominent vendors
• Boston Scientific
• Dextera Surgical
• Edwards Lifesciences
• Ethicon (a subsidiary of Johnson & Johnson)
• Genesee BioMedical
• Hancock Jaffe Laboratories
• HeartWare
• KARL STORZ
• LivaNova
• Neograft
• NOVADAQ
• Teleflex
• VASOPREP SURGICAL
• Vitalitec
Market driver
• Favorable reimbursement policies
• For a full, detailed list, view our report
Market challenge
• Availability of alternate treatments
• For a full, detailed list, view our report
Market trend
• Rise in medical tourism
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
CABG is a surgical procedure performed to improve blood flow to the heart. It is used for patients suffering with a severe coronary heart disease (CHD). CHD is a disease that leads to deposition of plaque inside arteries and disrupts the flow of oxygen to the heart. During the CABG procedure, a healthy artery or vein from the body is connected or grafted to the blocked coronary artery to create a new path for oxygen-rich blood to flow to the heart muscle.
Technavio’s analysts forecast the global coronary artery bypass grafts (CABG) market to grow at a CAGR of 5.83% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global coronary artery bypass grafts (CABG) market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott
• MAQUET
• Medtronic
• Terumo Medical
Other prominent vendors
• Boston Scientific
• Dextera Surgical
• Edwards Lifesciences
• Ethicon (a subsidiary of Johnson & Johnson)
• Genesee BioMedical
• Hancock Jaffe Laboratories
• HeartWare
• KARL STORZ
• LivaNova
• Neograft
• NOVADAQ
• Teleflex
• VASOPREP SURGICAL
• Vitalitec
Market driver
• Favorable reimbursement policies
• For a full, detailed list, view our report
Market challenge
• Availability of alternate treatments
• For a full, detailed list, view our report
Market trend
• Rise in medical tourism
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
